Jonathan D Salcedo, MD
Cardiac Electrophysiology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 5 carriers
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
17 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Salcedo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A113051 · Current
Licensed to practise in California · since 2010 · expires 2028-07-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$385,415
Medicare paid this office $385,415 for 804 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 277 | $72,179 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 123 | $63,214 | $506 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 117 | $35,098 | $187 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 117 | $33,399 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $20,239 | $195 |
See all 29 services
| Long return visit (40+ min) | 277 | $72,179 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 123 | $63,214 | $506 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 117 | $35,098 | $187 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 117 | $33,399 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $20,239 | $195 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 72 | $16,409 | $225 |
| New patient visit (60+ min) | 73 | $14,311 | $196 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 62 | $8,758 | $141 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $8,488 | $606 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $8,209 | $105 |
| Return visit (30+ min) | 57 | $7,530 | $116 |
| Programming of dual lead pacemaker system | 63 | $7,476 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 268 | $6,445 | $13 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,321 | $395 |
| Programming of heart rhythm stimulation after drug infusion | 136 | $5,682 | $41 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 279 | $5,213 | $15 |
| Long return visit (40+ min) | 35 | $4,691 | $127 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 76 | $4,281 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 68 | $4,228 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,540 | $154 |
| External shock to heart to regulate heart beat | 30 | $3,107 | $97 |
| Return visit (30+ min) | 32 | $2,705 | $85 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,455 | $223 |
| Ultrasound of heart, follow-up | 88 | $1,960 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 78 | $1,944 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $1,924 | $58 |
| Heart rhythm recording of continous external ekg over 8-15 days | 77 | $1,102 | $13 |
| 3d radiographic procedure | 29 | $822 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $208 | $10 |
Procedures Medicare counted
| Pacemaker insertion or repair | 37 | More than 83% of doctors who do this |
Who their Medicare patients are
804 Original Medicare patients in 2024. Average age 78 · Women 43% · Also on Medicaid 5% · Health risk score 1.34. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Coronary heart disease 36% · Heart failure 31% · Diabetes 21% · Chronic kidney disease 21% · Cancer 18% · Depression 12% · COPD 10% · Stroke 8% · Dementia 6%.
The office billed $1,888,882, Medicare allowed $495,233 and paid $385,415; for 3,633 services of 85 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 804 | 3,633 | 78 | 1.34 | $1,888,882 | $385,415 |
| 2023 | 699 | 3,061 | 78 | 1.25 | $1,825,545 | $373,001 |
| 2022 | 1,099 | 3,434 | 78 | 1.30 | $1,605,919 | $359,891 |
| 2021 | 1,009 | 3,560 | 78 | 1.21 | $1,669,742 | $412,516 |
| 2020 | 405 | 3,049 | 76 | 1.50 | $1,636,277 | $402,619 |
| 2019 | 456 | 3,723 | 76 | 1.39 | $1,755,110 | $391,971 |
| 2018 | 398 | 2,879 | 77 | 1.44 | $1,053,641 | $243,653 |
| 2017 | 369 | 2,178 | 76 | 1.53 | $970,137 | $245,079 |
| 2016 | 173 | 657 | 77 | 1.44 | $317,230 | $80,328 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 34 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 124 | $71,086 | $564 |
| Long return visit (40+ min) | 224 | $61,262 | $157 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 109 | $39,892 | $208 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 110 | $37,892 | $197 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 52 | $12,391 | $234 |
| New patient visit (60+ min) | 64 | $12,188 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $11,357 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $10,776 | $108 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $8,037 | $670 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,998 | $444 |
| Return visit (30+ min) | 63 | $7,834 | $104 |
| Programming of heart rhythm stimulation after drug infusion | 135 | $7,719 | $57 |
| Programming of dual lead pacemaker system | 61 | $7,482 | $79 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 42 | $6,193 | $144 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | $4,856 | $13 |
| Return visit (30+ min) | 52 | $4,620 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,341 | $155 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 66 | $3,641 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $3,633 | $24 |
| External shock to heart to regulate heart beat | 25 | $2,575 | $99 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 15 | $2,386 | $55 |
| Ultrasound of heart, follow-up | 80 | $1,896 | $23 |
| Long return visit (40+ min) | 14 | $1,831 | $131 |
| Programming of multiple lead pacemaker system | 11 | $1,764 | $84 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 63 | $1,741 | $23 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,369 | $105 |
| Heart rhythm recording of continous external ekg over 8-15 days | 65 | $993 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 34 | $788 | $22 |
| 3d radiographic procedure | 12 | $323 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 34 | $318 | $9 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $282 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 13 | $267 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $249 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 13 | $168 | $13 |
2022: 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 119 | $74,441 | $615 |
| Long return visit (40+ min) | 197 | $50,447 | $156 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 109 | $37,771 | $193 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 98 | $33,466 | $184 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 650 | $11,634 | $12 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $11,060 | $442 |
| New patient visit (60+ min) | 55 | $10,716 | $195 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 46 | $10,060 | $219 |
| Return visit (30+ min) | 73 | $9,986 | $112 |
| Programming of heart rhythm stimulation after drug infusion | 130 | $8,859 | $68 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $8,463 | $529 |
| Return visit (30+ min) | 75 | $6,872 | $89 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 46 | $6,496 | $141 |
| Programming of dual lead pacemaker system | 53 | $6,475 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $5,996 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,948 | $93 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,467 | $406 |
| External shock to heart to regulate heart beat | 36 | $3,480 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 77 | $3,374 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 64 | $2,999 | $24 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,881 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,667 | $167 |
| Ultrasound of heart, follow-up | 80 | $1,825 | $23 |
| Long return visit (40+ min) | 12 | $1,586 | $132 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 47 | $1,183 | $23 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 19 | $1,068 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 47 | $745 | $14 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $725 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 29 | $650 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $559 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $430 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $275 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 29 | $261 | $9 |
2021: 32 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 155 | $93,644 | $604 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 108 | $44,155 | $287 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 103 | $38,183 | $279 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 164 | $29,499 | $179 |
| Long return visit (40+ min) | 115 | $27,103 | $161 |
| Return visit (30+ min) | 152 | $20,868 | $106 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 26 | $15,938 | $613 |
| Programming of heart rhythm stimulation after drug infusion | 142 | $14,533 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 611 | $12,605 | $13 |
| New patient visit (60+ min) | 54 | $10,825 | $200 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 150 | $10,435 | $70 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $9,872 | $449 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $5,891 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $5,603 | $93 |
| Programming of dual lead pacemaker system | 46 | $5,271 | $76 |
| Return visit (30+ min) | 57 | $5,185 | $91 |
| External shock to heart to regulate heart beat | 42 | $4,226 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 51 | $3,256 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,075 | $171 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $2,999 | $25 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 28 | $2,458 | $88 |
| Ultrasound of heart, follow-up | 100 | $2,381 | $23 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,260 | $84 |
| Recording of upper heart rhythm | 13 | $1,367 | $105 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 52 | $1,342 | $23 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $854 | $71 |
| Heart rhythm recording of continous external ekg over 8-15 days | 50 | $823 | $14 |
| Short return visit (20+ min) | 13 | $799 | $61 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 30 | $708 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $532 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $315 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 29 | $285 | $10 |
2020: 38 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 122 | $103,358 | $807 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 87 | $47,559 | $358 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 77 | $30,151 | $355 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 120 | $29,969 | $236 |
| Return visit (30+ min) | 171 | $24,732 | $92 |
| Programming of heart rhythm stimulation after drug infusion | 119 | $16,353 | $130 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 119 | $11,590 | $93 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $10,980 | $439 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 17 | $10,189 | $599 |
| New patient visit (60+ min) | 44 | $7,923 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $7,019 | $96 |
| Long return visit (40+ min) | 38 | $5,511 | $134 |
| External shock to heart to regulate heart beat | 49 | $5,144 | $103 |
| Return visit (30+ min) | 63 | $4,722 | $73 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,627 | $421 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24 | $4,419 | $184 |
| Programming of dual lead pacemaker system | 45 | $3,973 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | $3,838 | $104 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 161 | $3,354 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 44 | $3,008 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 41 | $2,912 | $27 |
| Ultrasound of heart, follow-up | 113 | $2,835 | $24 |
| Ultrasonic guidance for blood vessel access | 106 | $2,815 | $13 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,778 | $185 |
| Recording of upper heart rhythm | 18 | $1,944 | $108 |
| External ekg recording for more than 48 hours up to 21 days | 57 | $1,746 | $27 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,701 | $100 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 57 | $1,555 | $24 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,541 | $64 |
| Interpretation and report of ultrasound of heart | 20 | $1,480 | $74 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,424 | $89 |
| Short return visit (20+ min) | 20 | $1,157 | $58 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 95 | $973 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 32 | $824 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 32 | $330 | $9 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $322 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $303 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $56 | $3 |
2019: 36 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 164 | $99,116 | $594 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 91 | $30,883 | $289 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 153 | $28,947 | $187 |
| Return visit (30+ min) | 166 | $26,226 | $92 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 86 | $22,168 | $252 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $16,908 | $445 |
| Programming of heart rhythm stimulation after drug infusion | 149 | $15,785 | $105 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 157 | $11,570 | $72 |
| Long return visit (40+ min) | 54 | $10,446 | $136 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $9,744 | $487 |
| Interpretation and report of ultrasound of heart | 117 | $9,735 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,309 | $94 |
| New patient visit (60+ min) | 39 | $7,302 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | $6,279 | $15 |
| Programming of dual lead pacemaker system | 46 | $5,620 | $60 |
| External shock to heart to regulate heart beat | 51 | $5,168 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $4,812 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,376 | $182 |
| Ultrasound of heart, follow-up | 168 | $4,042 | $24 |
| Ultrasonic guidance for blood vessel access | 129 | $3,291 | $13 |
| Recording of upper heart rhythm | 25 | $2,733 | $105 |
| Ultrasound of heart blood flow, valves and chambers | 117 | $2,004 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 29 | $1,759 | $27 |
| Return visit (30+ min) | 22 | $1,639 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $1,571 | $28 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 18 | $1,512 | $84 |
| External ekg recording for more than 48 hours up to 21 days | 42 | $1,197 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 43 | $1,129 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system | 12 | $940 | $36 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 91 | $855 | $6 |
| Short return visit (20+ min) | 18 | $830 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $529 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 22 | $498 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 117 | $350 | $3 |
| 3d radiographic procedure | 14 | $320 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 22 | $212 | $10 |
2018: 36 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 143 | $51,834 | $355 |
| Return visit (30+ min) | 134 | $20,998 | $92 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 119 | $16,030 | $130 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 30 | $13,013 | $434 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 53 | $9,253 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $8,801 | $91 |
| New patient visit (60+ min) | 43 | $7,599 | $177 |
| Long return visit (40+ min) | 45 | $6,991 | $123 |
| Programming of heart rhythm stimulation after drug infusion | 90 | $6,790 | $74 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 31 | $6,746 | $218 |
| Interpretation and report of ultrasound of heart | 74 | $5,936 | $80 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 132 | $5,876 | $44 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $5,468 | $342 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $5,368 | $199 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 168 | $5,124 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,357 | $174 |
| Programming of dual lead pacemaker system | 37 | $3,389 | $53 |
| Ultrasound of heart, follow-up | 116 | $2,789 | $23 |
| Recording of upper heart rhythm | 23 | $2,374 | $103 |
| New patient visit (45+ min) | 12 | $1,755 | $146 |
| Ultrasonic guidance for blood vessel access | 65 | $1,665 | $13 |
| External ekg recording for more than 48 hours up to 21 days | 49 | $1,384 | $27 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,366 | $98 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 49 | $1,246 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 74 | $1,222 | $17 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 103 | $1,103 | $6 |
| Short return visit (20+ min) | 13 | $1,004 | $63 |
| Return visit (30+ min) | 13 | $978 | $70 |
| Short return visit (20+ min) | 19 | $821 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 16 | $584 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $558 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 22 | $511 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $355 | $24 |
| 3d radiographic procedure | 11 | $273 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 22 | $218 | $9 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 75 | $215 | $3 |
2017: 32 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 118 | $56,142 | $449 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 114 | $22,232 | $184 |
| Long return visit (40+ min) | 76 | $14,066 | $118 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $12,229 | $453 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 29 | $11,743 | $367 |
| Return visit (30+ min) | 71 | $10,556 | $95 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 20 | $8,525 | $355 |
| Programming of heart rhythm stimulation after drug infusion | 53 | $7,803 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $7,161 | $93 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 113 | $6,494 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $6,372 | $228 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $6,280 | $483 |
| New patient visit (60+ min) | 32 | $5,968 | $187 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,230 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | $3,931 | $16 |
| Interpretation and report of ultrasound of heart | 38 | $3,374 | $80 |
| External shock to heart to regulate heart beat | 30 | $3,107 | $100 |
| Ultrasound of heart, follow-up | 80 | $1,989 | $23 |
| 3d radiographic procedure with computerized image postprocessing | 27 | $1,919 | $69 |
| Programming of dual lead pacemaker system | 19 | $1,477 | $55 |
| Ultrasonic guidance for blood vessel access | 54 | $1,401 | $13 |
| Recording of upper heart rhythm | 12 | $1,242 | $103 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 12 | $1,239 | $95 |
| External ekg recording for more than 48 hours up to 21 days | 40 | $1,187 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 40 | $1,095 | $23 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 103 | $833 | $6 |
| Return visit (30+ min) | 11 | $772 | $70 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 30 | $724 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $696 | $17 |
| Short return visit (20+ min) | 13 | $590 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 30 | $307 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $121 | $3 |
2016: 17 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 55 | $21,674 | $394 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 52 | $8,330 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $5,373 | $93 |
| Long return visit (40+ min) | 25 | $3,520 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,427 | $180 |
| New patient visit (60+ min) | 17 | $3,235 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,586 | $235 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 50 | $2,513 | $50 |
| Programming of heart rhythm stimulation after drug infusion | 19 | $2,386 | $126 |
| External shock to heart to regulate heart beat | 14 | $1,561 | $111 |
| Interpretation and report of ultrasound of heart | 11 | $1,007 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 42 | $718 | $16 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 55 | $527 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 11 | $240 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $200 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $107 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $35 | $3 |
Drugs they prescribed that Part D paid
$549,250
Pharmacies billed $549,250 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
981 generic and 412 brand-name prescriptions · $549,250 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 272 | $374,001 | $1,375 |
| Xarelto | 57 | $62,905 | $1,104 |
| Entresto | 19 | $31,572 | $1,662 |
| Jardiance | 12 | $17,995 | $1,500 |
| Dofetilide | 34 | $9,516 | $280 |
See all 29 drugs
| Eliquis | 272 | $374,001 | $1,375 |
| Xarelto | 57 | $62,905 | $1,104 |
| Entresto | 19 | $31,572 | $1,662 |
| Jardiance | 12 | $17,995 | $1,500 |
| Dofetilide | 34 | $9,516 | $280 |
| Flecainide Acetate | 47 | $4,117 | $88 |
| Metoprolol | 108 | $1,861 | $17 |
| Diltiazem 24hr Er (Cd) | 39 | $1,797 | $46 |
| Atorvastatin | 84 | $1,285 | $15 |
| Sotalol | 49 | $1,143 | $23 |
| Sotalol Af | 57 | $1,131 | $20 |
| Telmisartan | 11 | $608 | $55 |
| Olmesartan Medoxomil | 35 | $600 | $17 |
| Digoxin | 18 | $552 | $31 |
| Valsartan | 13 | $525 | $40 |
| Potassium Chloride | 15 | $517 | $34 |
| Carvedilol | 33 | $504 | $15 |
| Losartan | 51 | $414 | $8 |
| Furosemide | 42 | $386 | $9 |
| Pravastatin | 11 | $349 | $32 |
| Spironolactone | 29 | $320 | $11 |
| Rosuvastatin | 21 | $278 | $13 |
| Torsemide | 14 | $261 | $19 |
| Metoprolol | 34 | $194 | $6 |
| Amlodipine Besylate | 43 | $180 | $4 |
| Simvastatin | 12 | $89 | $7 |
| Lisinopril | 11 | $77 | $7 |
| Lorazepam | 11 | $74 | $7 |
| Atenolol | 14 | $27 | $2 |
Year by year
| 2024 | 1,393 | 229 | None | 30% | $549,250 |
| 2023 | 1,106 | 177 | None | 25% | $423,268 |
| 2022 | 827 | 152 | None | None | $261,264 |
| 2021 | 793 | 149 | None | 27% | $253,126 |
| 2020 | 755 | 136 | 2% (11) | 25% | $192,092 |
| 2019 | 681 | 115 | None | 25% | $147,095 |
| 2018 | 623 | 106 | None | 34% | $154,569 |
| 2017 | 575 | 89 | None | 33% | $93,028 |
| 2016 | 78 | 34 | None | 28% | $8,853 |
| 2015 | 14 | 11 | None | None | $392 |
| 2014 | 21 | None | None | 0% | $156 |
| 2013 | 41 | None | 0% (0) | 0% | $624 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Eliquis | 176 | $260,678 | $1,481 |
| Xarelto | 43 | $58,893 | $1,370 |
| Entresto | 13 | $23,028 | $1,771 |
| Multaq | 14 | $15,904 | $1,136 |
| Dofetilide | 28 | $14,950 | $534 |
| Flecainide Acetate | 43 | $2,820 | $66 |
| Atorvastatin | 77 | $1,775 | $23 |
| Metoprolol | 83 | $1,468 | $18 |
| Sotalol Af | 38 | $1,465 | $39 |
| Sotalol | 50 | $1,301 | $26 |
| Diltiazem 24hr Er (Cd) | 32 | $1,290 | $40 |
| Telmisartan | 12 | $1,026 | $86 |
| Digoxin | 22 | $713 | $32 |
| Amlodipine Besylate | 36 | $623 | $17 |
| Losartan | 35 | $559 | $16 |
| Atenolol | 17 | $489 | $29 |
| Olmesartan Medoxomil | 21 | $445 | $21 |
| Carvedilol | 32 | $430 | $13 |
| Furosemide | 37 | $398 | $11 |
| Potassium Chloride | 17 | $332 | $20 |
| Rosuvastatin | 16 | $268 | $17 |
| Simvastatin | 14 | $246 | $18 |
| Spironolactone | 23 | $194 | $8 |
| Metoprolol | 19 | $166 | $9 |
| Warfarin | 17 | $70 | $4 |
2022: 22 drugs
| Eliquis | 128 | $168,145 | $1,314 |
| Xarelto | 36 | $49,336 | $1,370 |
| Sotalol Af | 30 | $1,808 | $60 |
| Diltiazem 24hr Er (Cd) | 38 | $1,712 | $45 |
| Flecainide Acetate | 22 | $1,581 | $72 |
| Atorvastatin | 56 | $1,298 | $23 |
| Sotalol | 33 | $1,221 | $37 |
| Metoprolol | 57 | $1,137 | $20 |
| Olmesartan Medoxomil | 14 | $1,049 | $75 |
| Amlodipine Besylate | 24 | $469 | $20 |
| Potassium Chloride | 15 | $304 | $20 |
| Furosemide | 28 | $276 | $10 |
| Rosuvastatin | 20 | $262 | $13 |
| Losartan | 19 | $238 | $13 |
| Torsemide | 11 | $208 | $19 |
| Metoprolol | 17 | $186 | $11 |
| Lorazepam | 13 | $170 | $13 |
| Carvedilol | 27 | $164 | $6 |
| Spironolactone | 14 | $161 | $12 |
| Lisinopril | 14 | $129 | $9 |
| Simvastatin | 11 | $84 | $8 |
| Warfarin | 12 | $37 | $3 |
2021: 16 drugs
| Eliquis | 150 | $176,829 | $1,179 |
| Xarelto | 32 | $31,766 | $993 |
| Dofetilide | 21 | $8,578 | $408 |
| Flecainide Acetate | 27 | $2,303 | $85 |
| Sotalol Af | 23 | $2,170 | $94 |
| Diltiazem 24hr Er (Cd) | 33 | $1,611 | $49 |
| Metoprolol | 51 | $1,440 | $28 |
| Sotalol | 44 | $1,377 | $31 |
| Atorvastatin | 47 | $959 | $20 |
| Amlodipine Besylate | 28 | $550 | $20 |
| Losartan | 19 | $484 | $25 |
| Potassium Chloride | 16 | $394 | $25 |
| Furosemide | 14 | $186 | $13 |
| Carvedilol | 22 | $147 | $7 |
| Metoprolol | 18 | $129 | $7 |
| Lisinopril | 11 | $118 | $11 |
2020: 19 drugs
| Eliquis | 149 | $148,401 | $996 |
| Dofetilide | 17 | $4,993 | $294 |
| Telmisartan | 16 | $2,280 | $143 |
| Metoprolol | 51 | $2,125 | $42 |
| Sotalol Af | 26 | $1,276 | $49 |
| Sotalol | 30 | $1,227 | $41 |
| Flecainide Acetate | 15 | $1,017 | $68 |
| Atorvastatin | 56 | $913 | $16 |
| Diltiazem 24hr Er (Cd) | 13 | $594 | $46 |
| Cartia Xt | 12 | $550 | $46 |
| Potassium Chloride | 12 | $340 | $28 |
| Fenofibrate | 13 | $310 | $24 |
| Furosemide | 15 | $256 | $17 |
| Losartan | 24 | $247 | $10 |
| Amlodipine Besylate | 28 | $193 | $7 |
| Carvedilol | 24 | $191 | $8 |
| Lisinopril | 11 | $124 | $11 |
| Metoprolol | 16 | $119 | $7 |
| Lorazepam | 12 | $98 | $8 |
2019: 19 drugs
| Eliquis | 120 | $108,071 | $901 |
| Xarelto | 17 | $11,084 | $652 |
| Metoprolol | 51 | $2,045 | $40 |
| Sotalol | 33 | $1,125 | $34 |
| Flecainide Acetate | 14 | $991 | $71 |
| Sotalol Af | 21 | $759 | $36 |
| Cartia Xt | 16 | $742 | $46 |
| Atorvastatin | 41 | $693 | $17 |
| Warfarin | 22 | $483 | $22 |
| Torsemide | 11 | $471 | $43 |
| Losartan | 19 | $465 | $24 |
| Valsartan | 12 | $321 | $27 |
| Pantoprazole | 15 | $266 | $18 |
| Furosemide | 32 | $263 | $8 |
| Fenofibrate | 11 | $252 | $23 |
| Amlodipine Besylate | 22 | $252 | $11 |
| Metoprolol | 11 | $108 | $10 |
| Lorazepam | 12 | $66 | $6 |
| Carvedilol | 12 | $58 | $5 |
2018: 17 drugs
| Eliquis | 148 | $108,306 | $732 |
| Xarelto | 32 | $22,919 | $716 |
| Ezetimibe | 15 | $3,283 | $219 |
| Metoprolol | 34 | $1,539 | $45 |
| Sotalol Af | 13 | $1,030 | $79 |
| Flecainide Acetate | 11 | $834 | $76 |
| Cartia Xt | 22 | $731 | $33 |
| Atorvastatin | 22 | $517 | $24 |
| Valsartan | 17 | $445 | $26 |
| Sotalol | 20 | $354 | $18 |
| Torsemide | 11 | $285 | $26 |
| Amlodipine Besylate | 36 | $284 | $8 |
| Losartan | 22 | $239 | $11 |
| Metoprolol | 18 | $194 | $11 |
| Furosemide | 24 | $188 | $8 |
| Hydrochlorothiazide | 12 | $121 | $10 |
| Lisinopril | 12 | $82 | $7 |
2017: 18 drugs
| Eliquis | 127 | $61,318 | $483 |
| Xarelto | 24 | $14,798 | $617 |
| Metoprolol | 29 | $1,405 | $48 |
| Sotalol Af | 13 | $810 | $62 |
| Valsartan | 14 | $511 | $37 |
| Sotalol | 22 | $461 | $21 |
| Cartia Xt | 27 | $321 | $12 |
| Diltiazem 24hr Er | 21 | $270 | $13 |
| Potassium Chloride | 17 | $257 | $15 |
| Amlodipine Besylate | 29 | $204 | $7 |
| Warfarin | 12 | $203 | $17 |
| Metoprolol | 12 | $196 | $16 |
| Amiodarone | 14 | $191 | $14 |
| Lisinopril | 17 | $189 | $11 |
| Losartan | 16 | $152 | $9 |
| Torsemide | 11 | $119 | $11 |
| Furosemide | 32 | $101 | $3 |
| Atenolol | 11 | $24 | $2 |
2016: 1 drug
| Eliquis | 13 | $4,731 | $364 |
Money from drug and device companies
$8,157 in 2025
| 2025 | 10 | 59 | $4,100 | $8,157 |
| 2024 | 7 | 21 | $3,563 | $5,059 |
| 2023 | 9 | 51 | $17,063 | $22,128 |
| 2022 | 10 | 43 | None | $2,850 |
| 2021 | 7 | 15 | None | $1,391 |
| 2020 | 3 | 6 | None | $162 |
| 2019 | 18 | 58 | None | $1,661 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Tacticath Ablation Catheter, Sensor Enabled | $4,112 | 20 payments
|
| Biosense Webster | Carto 3 | $2,066 | 8 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $873 | 10 payments
|
| Boston Scientific | Watchman Flx | $397 | 9 payments
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $305 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $136 | 2 payments
|
See all 59 published payments
| Abbott Laboratories | Meals · 2025-11-26 | Perclose Prostyle | $99 |
| Abbott Laboratories | Meals · 2025-11-24 | Perclose Proglide | $24 |
| Biosense Webster | Meals · 2025-10-28 | Soundstar | $29 |
| Abbott Laboratories | Meals · 2025-10-27 | Agilis | $29 |
| Medtronic | Meals · 2025-10-16 | Azure Xt Dr Mri Surescan | $70 |
| Medtronic | Meals · 2025-10-10 | Affera Mapping System | $50 |
| Boston Scientific | Meals · 2025-09-25 | Farapulse | $35 |
| AtriCure | Meals · 2025-09-18 | Synergy Ablation System | $186 |
| Boston Scientific | Meals · 2025-09-16 | Farapulse | $42 |
| Boston Scientific | Meals · 2025-09-15 | Farapulse | $33 |
| Boston Scientific | Meals · 2025-09-15 | Farapulse | $19 |
| AtriCure | Meals · 2025-08-18 | Atriclip Laa Exclusion System | $27 |
| Biosense Webster | Meals · 2025-08-13 | Nuvision Ice Catheter | $26 |
| Abbott Laboratories | Meals · 2025-08-12 | Ensite | $137 |
| Biosense Webster | Meals · 2025-07-30 | Carto 3 | $144 |
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-07-17 | Epi-Sense Guided Coagulation System With Visitrax | $37 |
| Abbott Laboratories | Meals · 2025-07-17 | Viewmate | $29 |
| Abbott Laboratories | Meals · 2025-07-10 | Aveir | $137 |
| Biosense Webster | Consulting · 2025-06-27 | Carto 3 | $1,800 |
| Abbott Laboratories | Meals · 2025-06-27 | Agilis | $25 |
| Abbott Laboratories | Meals · 2025-06-25 | Ensite | $116 |
| Abbott Laboratories | Meals · 2025-06-11 | Ensite | $174 |
| Abbott Laboratories | Meals · 2025-06-05 | Aveir | $139 |
| Abbott Laboratories | Travel · 2025-06-04 | Tacticath Ablation Catheter, Sensor Enabled | $258 |
| Biosense Webster | Meals · 2025-05-30 | Carto 3 | $5 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-29 | Lifevest | $22 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| Abbott Laboratories | Consulting · 2025-05-27 | Tacticath Ablation Catheter, Sensor Enabled | $2,300 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $36 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $11 |
| Impulse Dynamics (USA) | Meals · 2025-05-15 | Optimizer | $44 |
| Boston Scientific | Meals · 2025-05-09 | Farapulse | $37 |
| Abbott Laboratories | Travel · 2025-05-09 | Tacticath Ablation Catheter, Sensor Enabled | $205 |
| Abbott Laboratories | Travel · 2025-05-09 | Tacticath Ablation Catheter, Sensor Enabled | $133 |
| Abbott Laboratories | Travel · 2025-05-09 | Tacticath Ablation Catheter, Sensor Enabled | $9 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-01 | Camzyos | $131 |
| Boston Scientific | Meals · 2025-04-29 | Farapulse | $29 |
| Biotronik | Meals · 2025-04-25 | Selectra | $23 |
| Biotronik | Meals · 2025-04-25 | Acticor 7 Vr-T Dx | $36 |
| AtriCure | Meals · 2025-04-24 | Epi-Sense Guided Coagulation System With Visitrax | $148 |
| Biotronik | Meals · 2025-04-24 | Acticor 7 Vr-T Dx | $21 |
| Philips North America | Meals · 2025-04-11 | Ambulatory Monitoring & Diagnostics Undivided | $122 |
| AtriCure | Meals · 2025-04-10 | Synergy Ablation System | $23 |
| Biosense Webster | Meals · 2025-04-05 | Nuvision Ice Catheter | $26 |
| Biosense Webster | Meals · 2025-03-29 | Carto 3 | $4 |
| Biosense Webster | Meals · 2025-03-27 | Carto 3 | $32 |
| Boston Scientific | Meals · 2025-03-26 | Watchman Flx | $51 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
| Abbott Laboratories | Meals · 2025-03-17 | Ensite | $214 |
| Boston Scientific | Meals · 2025-03-12 | Watchman Flx | $51 |
| Abbott Laboratories | Meals · 2025-03-11 | Perclose Prostyle | $24 |
| Medtronic | Meals · 2025-03-07 | Micra | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-06 | Camzyos | $5 |
| Boston Scientific | Meals · 2025-01-23 | Watchman Flx | $101 |
| Abbott Laboratories | Meals · 2025-01-21 | Perclose Prostyle | $29 |
| Abbott Laboratories | Meals · 2025-01-13 | Perclose Prostyle | $9 |
| Abbott Laboratories | Meals · 2025-01-13 | Perclose Prostyle | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,059
| Medical Device Business Services | Carto 3 | $3,563 | 2 payments
|
| Boston Scientific | Rhythmia Mapping System | $607 | 7 payments
|
| Impulse Dynamics (USA) | Optimizer | $347 | 2 payments
|
| Abbott Laboratories | Ensite Precision | $192 | 6 payments
|
| Kestra Medical Technology Services | Assure Wcd | $184 | 2 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
| Philips North America | (5044) Mcot | $18 | 1 payment
|
2023: $22,128
| Medtronic | Selectsecure | $11,459 | 16 payments
|
| Medical Device Business Services | Carto 3 | $4,875 | 3 payments
|
| Abbott Laboratories | Ensite | $4,070 | 14 payments
|
| Philips Electronics North America | (5044) Mcot | $457 | 6 payments
|
| Ablacon | None | $398 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $364 | 3 payments
|
| Biosense Webster | Carto 3 | $361 | 4 payments
|
| Boston Scientific | Rhythmia Mapping System | $81 | 2 payments
|
| Kestra Medical Technology Services | Assure Wcd | $63 | 1 payment
|
2022: $2,850
| Abbott Laboratories | Ensite Precision | $1,032 | 14 payments
|
| Impulse Dynamics (USA) | Optimizer | $573 | 4 payments
|
| Boston Scientific | Watchman Access System | $321 | 4 payments
|
| Biosense Webster | Carto 3 | $224 | 2 payments
|
| Biotronik | Biomonitor | $190 | 2 payments
|
| Medtronic | Cobalt Dr Mri Surescan | $152 | 2 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $137 | 10 payments
|
| Philips Electronics North America | (5044) Mcot | $102 | 1 payment
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $100 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
2021: $1,391
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $567 | 4 payments
|
| Medtronic | Micra | $299 | 3 payments
|
| Biotronik | Rivacor | $177 | 2 payments
|
| Biosense Webster | Carto 3 | $121 | 1 payment
|
| Atricure | Synergy Ablation System | $116 | 1 payment
|
| Shockwave Medical | Vascular Lithotripsy | $60 | 3 payments
|
| Medical Device Business Services | Carto 3 | $50 | 1 payment
|
2020: $162
| Abbott Laboratories | Confirm Rx | $79 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $63 | 3 payments
|
| Amgen | Repatha | $20 | 1 payment
|
2019: $1,661
| Abbott Laboratories | Ensite Cardiac Mapping System | $363 | 3 payments
|
| Biotronik | None | $287 | 4 payments
|
| Amgen | Repatha | $206 | 7 payments
|
| Sanofi-Aventis U.S. | Praluent | $128 | 6 payments
|
| Regeneron Healthcare Solutions | Praluent | $127 | 9 payments
|
| Pfizer | Eliquis | $121 | 9 payments
|
| Medtronic Vascular | Azure | $91 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $89 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $71 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $27 | 2 payments
|
| Lundbeck | Northera | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $21 | 1 payment
|
| Novo Nordisk | Ozempic | $20 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $19 | 1 payment
|
| Biosense Webster | Carto 3 System Rmt | $18 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $17 | 1 payment
|
| Boston Scientific | General Therapies | $17 | 1 payment
|
| Daiichi Sankyo | Injectafer | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Abbott Atrial Fibrillation Post Approval Study · 2023 | Their institution | $27,821 |
| Abbott Laboratories · Abbott Atrial Fibrillation Post Approval Study · 2024 | Their institution | $3,654 |
| BOSTON SCIENTIFIC CORPORATION · Advent · 2022 | Their institution | $2,750 |
| Abbott Laboratories · Nct05434650--Abbott Atrial Fibrillation Post Approval Study · 2025 | Their institution | $2,648 |
| Abbott Laboratories · Abbott Atrial Fibrillation Post Approval Study · 2022 | Their institution | $44 |
| Abbott Laboratories · Abbott Af Post Approval Study · 2024 | Their institution | $36 |
Professional record
- NPI
- 1699905190
- Licence
- CA 957776, CA A113051California A113051: Current · expires 2028-07-31
- Trained
- University of California, Irvine, California College of Medicine, 2008
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2009-07-17
- NPI last updated
- 2020-05-29
- NPI record certified
- 2020-05-29
This is when the NPI record was last certified, not a medical board exam.